HIF1A and central nervous system cancer: In recent years, the contribution of HIF-1-mediated P-gp expression to hypoxia-induced drug resistance has been observed in many tumor cells, such as gastric cancer, gliomas, and breast carcinoma [14], [21], [26], [36].